PharmaNet names Posener as neuroscience medical director
This article was originally published in Scrip
PharmaNet has appointed Dr Joel Posener as executive medical director of its Neuroscience division. Prior to joining the CRO, Dr Posener held various roles at Wyeth (now Pfizer), including senior director of neuroscience, and senior director of early development and clinical pharmacology. He directed Phase II projects in a variety of psychiatric indications including cognitive impairment in schizophrenia, bipolar disorder and depression. PharmaNet has conducted more than 100 neuroscience clinical trials in the past five years.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"